Health Condition 1: M797- Fibromyalgia
Conditions
Interventions
Intervention1: Desensitisation with intravenous lignocaine: 5 mg/kg body weight Lignocaine (2%) preservative free will be given intravenously with 100 ml normal saline over 1 hour. It will be given fo
Sponsors
ESI Institute of Pain Management
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients suffering from fibromyalgia with Widespread Pain Index(WPI)more than 7 and Symptom Severity Index(SSS) more than 5 or WPI 4-6 and SSS more than 9 2. Duration of fibromyalgia more than 12 weeks 3. Patient taking anti-neuropathic medicine more than 4 weeks 4. Degree of pain more than 5 according to VAS
Exclusion criteria
Exclusion criteria: 1. Patients with allergy to lignocaine 2. History of cardiac dysrrythmias 3. Patients with severe hepatic and renal disease 4. Patients not giving consent 5. Poorly controlled psychiatric conditions with possible secondary gain or severe comorbidity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Widespread Pain Index(WPI) and Symptom Severity Index(SSS)Timepoint: will be noted prior to the procedure and 1, 4 and 6 weeks after the procedure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Brief Pain Inventory(BPI) scoreTimepoint: will be noted prior to the procedure and 1, 4 and 6 weeks after the procedure.;Pain score using Visual Analogue ScaleTimepoint: will be noted prior to the procedure and 1, 4 and 6 weeks after the procedure. | — |
Countries
India
Contacts
Public ContactDr Subrata Goswami
ESI Institute of Pain Management
Outcome results
None listed